6 Firms Drive Thermo Fisher's $11.5B Deal For Qiagen

Law360 (March 3, 2020, 9:18 AM EST) -- Thermo Fisher Scientific has agreed to snap up German genetic testing company Qiagen for roughly $11.5 billion, the companies said Tuesday, in a deal put together with help from Wachtell Lipton, De Brauw Blackstone, Linklaters, Mintz Levin, Axinn Veltrop & Harkrider LLP and Freshfields.

The transaction, rumored since November, sees a major microscope supplier in Waltham, Massachusetts-based Thermo Fisher Scientific Inc. picking up a genetic testing company in Qiagen that boasts over 35 global locations across more than 25 countries and had revenue of $1.53 billion last year, according to a statement. The deal values Qiagen NC at $11.5 billion, including about...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!